Evolution of Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation (PREV) Program: a Prospective Cohort Study.
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Sponsor
- Laval University
- Enrollment
- 80
- Locations
- 1
- Primary Endpoint
- Change in toe pressure measurement
Study Overview
Brief Summary
The main purpose of this study is to evaluate the hemodynamic changes in the forefoot of patients with coronary, cerebrovascular or peripheral atherosclerotic disease referred a 12-week cardiovascular rehabilitation program (PREV program).
Also, this study will describe the characteristics of patients admitted to the PREV program and their evolutions in terms of favorable, unfavorable outcomes and complications and up to one year after completion of the program.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Prevention
- Masking
- None
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Any individual aged 18 years and older who has been diagnosed with peripheral artery disease, coronary artery disease, angina, ischemic heart failure, transient ischemic attack or ischemic stroke (non-cardioembolic, non-hemorrhagic);
- •Have been admitted to the PREV program;
Exclusion Criteria
- •Being not able to give written informed consent;
Arms & Interventions
Cardiovascular rehabilitation program
Intervention: Cardiovascular rehabilitation program (Other)
Outcomes
Primary Outcomes
Change in toe pressure measurement
Time Frame: Change from baseline to 12 weeks
Results will be measured in mm Hg
Change in the toe-brachial index
Time Frame: Change from baseline to 12 weeks
Change in the ankle-brachial index
Time Frame: Change from baseline to 12 weeks
Secondary Outcomes
- Short Form Health Survey 36 (SF-36)(Change from baseline to 12 weeks)
- Change in 6-minute walk test (6MWT)(Change from Baseline to 12 weeks)
Investigators
Jérôme Patry
Principal Investigator
Laval University